Search
Jilin Aodong: Taonan Pharmaceutical Subsidiary Secures Updated National Drug Standard for Calf Spleen Extract Injection
1 week ago /
Read about 0 minute
Author：小编
Jilin Aodong's subsidiary, Taonan Pharmaceutical, has successfully obtained the issuance of the revised national drug standard for "calf spleen extract injection." This updated standard features enhancements across multiple testing items, incorporating new requirements and methodologies. While this revision presents favorable conditions for the advancement of Taonan Pharmaceutical, the impact on drug sales remains uncertain amidst fluctuating market conditions.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
